Trulieve Cannabis Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $6.4
- Today's High:
- $7.14
- Open Price:
- $7
- 52W Low:
- $3.42
- 52W High:
- $16.11
- Prev. Close:
- $7.2
- Volume:
- 667985
Company Statistics
- Market Cap.:
- $1.08 billion
- Book Value:
- 7.883
- Revenue TTM:
- $1.18 billion
- Operating Margin TTM:
- 5.67%
- Gross Profit TTM:
- $683.04 million
- Profit Margin:
- -55.78%
- Return on Assets TTM:
- 1.34%
- Return on Equity TTM:
- -29.92%
Company Profile
Trulieve Cannabis Corp had its IPO on under the ticker symbol TCNNF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Trulieve Cannabis Corp has a staff strength of 5,900 employees.
Stock update
Shares of Trulieve Cannabis Corp opened at $7 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $6.4 - $7.14, and closed at $6.78.
This is a -5.83% slip from the previous day's closing price.
A total volume of 667,985 shares were traded at the close of the day’s session.
In the last one week, shares of Trulieve Cannabis Corp have increased by +17.26%.
Trulieve Cannabis Corp's Key Ratios
Trulieve Cannabis Corp has a market cap of $1.08 billion, indicating a price to book ratio of 0.8303 and a price to sales ratio of 1.2632.
In the last 12-months Trulieve Cannabis Corp’s revenue was $1.18 billion with a gross profit of $683.04 million and an EBITDA of $244.25 million. The EBITDA ratio measures Trulieve Cannabis Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Trulieve Cannabis Corp’s operating margin was 5.67% while its return on assets stood at 1.34% with a return of equity of -29.92%.
In Q2, Trulieve Cannabis Corp’s quarterly earnings growth was a negative -6.7% while revenue growth was a negative 10.2%.
Trulieve Cannabis Corp’s PE and PEG Ratio
- Forward PE
- 24.3902
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-4.52 per share while it has a forward price to earnings multiple of 24.3902 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Trulieve Cannabis Corp’s profitability.
Trulieve Cannabis Corp stock is trading at a EV to sales ratio of 1.9984 and a EV to EBITDA ratio of 12.03. Its price to sales ratio in the trailing 12-months stood at 1.2632.
Trulieve Cannabis Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $2.81 billion
- Total Liabilities
- $240.60 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $14.01 million
- Dividend Payout Ratio
- 0%
Trulieve Cannabis Corp ended 2024 with $2.81 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.81 billion while shareholder equity stood at $1.47 billion.
Trulieve Cannabis Corp ended 2024 with $0 in deferred long-term liabilities, $240.60 million in other current liabilities, in common stock, $-581800000.00 in retained earnings and $483.90 million in goodwill. Its cash balance stood at $152.40 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $511.60 million.
Trulieve Cannabis Corp’s total current assets stands at $474.80 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.00 million compared to accounts payable of $75.50 million and inventory worth $252.80 million.
In 2024, Trulieve Cannabis Corp's operating cash flow was $0 while its capital expenditure stood at $14.01 million.
Comparatively, Trulieve Cannabis Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $6.78
- 52-Week High
- $16.11
- 52-Week Low
- $3.42
- Analyst Target Price
- $
Trulieve Cannabis Corp stock is currently trading at $6.78 per share. It touched a 52-week high of $16.11 and a 52-week low of $16.11. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $4.49 and 200-day moving average was $5.9 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 884.6% of the company’s stock are held by insiders while 764.8% are held by institutions.
Frequently Asked Questions About Trulieve Cannabis Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, California, Maryland, Massachusetts, West Virginia, and Connecticut; and affiliated dispensaries in Pennsylvania. It also operated cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Massachusetts, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.